专题:Systemic Sclerosis and Related Diseases

This cluster of papers focuses on the pathogenesis, clinical manifestations, and treatment of systemic sclerosis, with an emphasis on fibrosis, autoantibodies, pulmonary involvement, and the role of TGF-ß signaling. It also explores genetic markers, endothelial dysfunction, and various treatment approaches including immunosuppressive therapy for this complex autoimmune disease.
最新文献
EULAR recommendations for the treatment of systemic sclerosis: 2023 update

article Full Text OpenAlex

Enpatoran, a Toll-like receptor 7/8 inhibitor, in moderate-to-severe systemic lupus erythematosus: findings from Cohort B of a multicentre, international, double-blind, placebo-controlled dose-finding phase 2 trial

article Full Text OpenAlex

A Phase 3 Trial of Brepocitinib in Dermatomyositis

article Full Text OpenAlex

Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus

article Full Text OpenAlex

Safety and efficacy of blinatumomab in the treatment of refractory systemic sclerosis: a case series

article Full Text OpenAlex

Reciprocal regulation of fibroblast–macrophage equilibrium governs skin integrity

article Full Text OpenAlex

Bispecific T cell engagers for treatment-refractory autoimmune connective tissue diseases

article Full Text OpenAlex

Fibroblasts as regulators of lung immunity, repair and fibrosis

review Full Text OpenAlex

Mechanisms of fibrotic tissue remodelling: insights from systemic sclerosis

review Full Text OpenAlex

Most Promising Emerging Therapies for Pulmonary Fibrosis: Targeting Novel Pathways

review Full Text OpenAlex

近5年高被引文献
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

article Full Text OpenAlex 1101 FWCI232.235

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension

article Full Text OpenAlex 740 FWCI136.6236

Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study

review Full Text OpenAlex 631 FWCI18.2611

Systemic sclerosis

review Full Text OpenAlex 628 FWCI18.1303

Interstitial lung diseases

review Full Text OpenAlex 552 FWCI17.6188

Systemic Lupus Erythematosus

review Full Text OpenAlex 549 FWCI40.6991

2023 ACR/EULAR antiphospholipid syndrome classification criteria

article Full Text OpenAlex 492 FWCI102.1928

The 2023 ACR / EULAR Antiphospholipid Syndrome Classification Criteria

article Full Text OpenAlex 489 FWCI101.9842

EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome

article Full Text OpenAlex 410 FWCI58.5362

Systemic lupus erythematosus

review Full Text OpenAlex 407 FWCI30.4495